Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Samfine Creation Holdings (SFHG) Cash & Equivalents (2023 - 2025)

Samfine Creation Holdings' Cash & Equivalents history spans 3 years, with the latest figure at $4.0 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 30.19% year-over-year to $4.0 million; the TTM value through Dec 2025 reached $4.0 million, down 30.19%, while the annual FY2025 figure was $4.0 million, 30.16% down from the prior year.
  • Cash & Equivalents reached $4.0 million in Q4 2025 per SFHG's latest filing, down from $5.7 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $5.7 million in Q4 2024 to a low of $2.2 million in Q4 2023.
  • Average Cash & Equivalents over 3 years is $4.0 million, with a median of $4.0 million recorded in 2025.
  • Peak YoY movement for Cash & Equivalents: surged 158.59% in 2024, then crashed 30.19% in 2025.
  • A 3-year view of Cash & Equivalents shows it stood at $2.2 million in 2023, then soared by 158.59% to $5.7 million in 2024, then plummeted by 30.19% to $4.0 million in 2025.
  • Per Business Quant, the three most recent readings for SFHG's Cash & Equivalents are $4.0 million (Q4 2025), $5.7 million (Q4 2024), and $2.2 million (Q4 2023).